Abstract
Objectives
To evaluate comorbidity and clinical features in elderly patients with dementia to determine differences according to dementia severity.
Design
Observational study with medical record review.
Setting
Eight hospitals in the Barcelona area.
Participants
515 consecutive admissions aged > 64 years with dementia, 89.1% of whom lived in the community.
Measurements
We collected data on sociodemographic variables, type of dementia, Barthel Index (BI), Lawton and Brody Index (LI), Mini-Mental State Examination (MMSE), Charlson Index and the total number of drugs chronically prescribed. We stratified the population into two groups according to disease severity with the Global Deterioration Scale (GDS): mild-moderate (GDS 3–5) and severe (GDS 6–7).
Results
There were a total of 515 participants of which 364 females (70%) and 151 males with a mean age of 81 ± 6 years old. The total number of chronic prescription drugs was 5.6 ± 2.4. The mean Charlson Index score was 2 ± 1.2. The 270 (52.5%) patients with a GDS score of 3–5 were compared with the 245 patients with a GDS score of 6–7. In the multivariate analysis, a GDS score of 6–7 was associated with poorer LI, BI, and MMSE scores and greater neuroleptic therapy.
Conclusions
Important comorbidity conditions are common in elderly individuals with dementia. The patients with more severe dementia had poor functional status and higher frequency of neuroleptic use. Medical comorbidities should be taken into account in the management of patients with dementia.
Similar content being viewed by others
References
De Ronchi D, Berardi D, Menchetti M, et al. Occurrence of cognitive impairment and dementia after the age of 60: a population based study from Northern Italy. Dement Geriatr Cogn Disord 2005; 19: 97–105.
Wolff JL, Strafield B, Anderson G. Prevalence, expenditures and complications of multiple chronic conditions of the elderly. Arch Intern Med 2002; 162: 2269–2276.
Fried L. Establishing Benchmarks for Quality Care for an Aging Population: Caring for Vulnerable Older Adults. Ann Intern Med 2003; 139: 784–786.
Albert SM, Costa R, Merchant C, Small S, Jenders RA, Stern Y. Hospitalization and Alzheimer’s disease: results from a community-based study. J Gerontol A Biol Sci Med Sci 1999; 54: M267–M271.
Formiga F, Fort I, Robles MJ, Barranco E, Espinosa MC, Riu S. Comorbilidad en pacientes ancianos con demencia. Diferencias por edad y genero. Rev Clin Esp 2007; 207: 495–500.
Lyketsos CG, Toone L, Tschanz J, et al. Population-based study of medical comorbidity in early dementia and “cognitive impairment, no dementia” (CIND). Association with functional and cognitive impairment: The Cache County Study. Am J Geriatr Psychiatry 2005; 13: 656–664.
Doraiswamy PM, Leon J, Cummings JL, Marin D, Neumann PJ. Prevalence and impact of medical comorbidity in Alzheimer’s disease. J Gerontol Med Sci 2002; 87: M173–M77.
Sanderson M, Wang J, Davis DR, Lane MJ, Cornman CB, Fadden MK. Comorbidity associated with dementia. Am J Alzheimer Dis Other Demen 2002; 17: 737–738.
Fu C, Chute DJ, Farga ES, Garakian J, Cummings JF, Vinters HV. Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med. 2004; 128: 32–38.
Formiga F, Fort I, Robles MJ, Riu S, Rodríguez D, Sabartes O. Aspectos diferenciales de comorbilidad en pacientes ancianos con demencia tipo Alzheimer o con demencia vascular. Rev Neurol 2008: 46:72–76.
Artaz MA, Boddaert J, Hériche-Taillandier E, Dieudonné B, Verny M, le group REAL.FR. Medical comorbidity in Alzheimer’s disease: baseline characteristics of the REAL.FR Cohort. Rev Med Interne. 2006; 27: 91–97.
Van Dijk PT, Dippel DW, Van Der Meulen JH, Habbema JD. Comorbidity and its effect on mortality in nursing home patients with dementia. J Nerv Ment Dis 1996; 184: 180–187.
American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 4th ed. APA: Washington, DC; 1993.
Reisberg B, Ferris SH, De Leon MJ, Crok T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982. 139: 1136–1139.
Mc Khann C, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34: 939–944.
Román GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250–260.
McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 1999; 53: 902–905.
Brun A, Englund B, Gustafson L, et al. The Lund and Manchester groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57: 416–418
Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965; 14: 61–65.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9:179–186.
Shah S. Vanclay F, Cooper B. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol 1989: 42: 703–709.
Folstein MF, Folstein SE, McHugh PR. “Mini mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.
Buchner DM, Hornbrook MC, Kutner NG, et al. Development of the common data base for the FICSIT trials. J Am Geriatr Soc 1993; 41: 297–308.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383.
Schubert CC, Boustani M, Callahan CM, et al. Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc 2006; 54: 104–109.
Lyketsos CG, Sheppard JMES, Rabins PV. Dementia in elderly persons in the general hospital. Am J Psychatry 2000; 157: 704–707.
McCormick WC, Kukull WA, van Belle G, Bowen JD, Teri L, Larson EB. Symptom patterns and comorbidity in the early stages of Alzheimer’s disease. J Am Geriatr Soc 1994; 42: 517–521.
Helmer C, Pérès K, Letenneur L, et al. Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity. Dement Geriatr Cogn Disord 2006; 22: 87–94.
Paul RH, Cohen RA, Moser DJ, et al. The Global Deterioration Scale: Relationships to neuropsychological performance and activities of daily living in patients with vascular dementia. J Geriatr Psychiatr Neurol 2002; 15: 50–54.
Gambassi G, Lapane KL, Landi F, Sgadari A, Mor V, Bernadie R. Gender differences in the relation between comorbidity and mortality of patients with Alzheimer’s disease. Neurology 1999; 53: 508–516.
Aguero-Torres H, Thomas VS, Winblad B, Fratiglioni L. The impact of somatic and cognitive disorders on the functional status of the elderly. J Clin Epidemiol 2002; 55: 1007–1012.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Formiga, F., Fort, I., Robles, M.J. et al. Comorbidity and clinical features in elderly patients with dementia: Differences according to dementia severity. J Nutr Health Aging 13, 423–427 (2009). https://doi.org/10.1007/s12603-009-0078-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-009-0078-x